跳至主要内容
临床试验/IRCT201011085140N1
IRCT201011085140N1已完成未知

Effect of Prophylactic Fibrinogen Concentrate Infusion on Postoperative Bleeding in Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blinded Clinical Trial

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 75 years(—)
性别
All

入选标准

  • All candidates for first time elective coronary artery bypass graft surgery. Exclusion criteria: 1-Previously diagnosed hematologic or liver disease, 2-uncontrolled or insulin dependent diabetic mellitus, 3-pregnancy, 4-unstable angina, 5-serum creatinine > 130 µmol/L, 6-left ventricular ejection fraction of less than 35% prior to surgery, 7-serum fibrinogen levels of more than 3/5 g/L.

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
1 期
Effect of prophylactic fibrinogen concentrate in surgery of abnormal lateral curvature of the spine: A randomized pilot study (EFISS trial)MedDRA version: 20.0Level: PTClassification code 10039727Term: Scoliosis surgerySystem Organ Class: 10042613 - Surgical and medical proceduresScoliosis
EUCTR2021-005493-25-CZFakultní nemocnice Brno32
招募中
3 期
Effect of fibrinogen on bleeding during pelvic surgery
IRCT20200109046064N1Iran University of Medical Sciences42
尚未招募
3 期
The administration of fibrinogen concentrate (a component of blood involved in clotting process) to be given to those women who, after delivery of babies, develop severe bleeding to establish if this drug will prevent further blood loss or reduce the volume of blood loss.Post partum haemorrhageReproductive Health and Childbirth - Childbirth and postnatal careBlood - Clotting disorders
ACTRN12614000691640Auckland City Hospital245
进行中(未招募)
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency - NDCongenital fibrinogen deficiency ( afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 9.1Level: LLTClassification code 10016075
EUCTR2007-004088-22-ITCSL BEHRING GmbH23
进行中(未招募)
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiencyFibrinogen Concentrate (Human) (FCH) - efficacy and safetyCongenital fibrinogen deficiency (afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 12.0Level: LLTClassification code 10016075Term: Factor I deficiency
EUCTR2007-004088-22-DECSL Behring GmbH23
Effect of prophylactic fibrinogen on post operative... | 临床试验